Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
807.86
+0.43 (+0.05%)
Official Closing Price
Updated: 7:00 PM EDT, May 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
May 28, 2024
Via
Benzinga
Nvidia's Meteoric Rise: How Does It Compare To Other Market Rallies?
May 28, 2024
Bespoke analysts compared Nvidia to Microsoft, Amazon and Apple. Here's what the experts determined about the company's stock rally.
Via
Benzinga
A New Name in Weight Loss Drugs
May 28, 2024
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Via
The Motley Fool
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF
May 28, 2024
As weight loss drugs are gaining popularity Roundhill GLP 1 And Weight Loss ETF (OZEM) has launched as anew way to invest in them.
Via
InvestorPlace
Topics
ETFs
The Dividend Acceleration Squad: 3 Stocks With Rapidly Rising Yields
May 28, 2024
Dividend stocks that grow their returns faster than others are worth considering for investors interested in growing their incomes.
Via
InvestorPlace
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
May 23, 2024
This winner can't stop winning.
Via
The Motley Fool
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
May 28, 2024
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.
Via
The Motley Fool
'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches
May 28, 2024
Ricks highlighted that the company is trying to prove the efficacy of its drugs for not only weight loss but also obesity-driven diseases such as heart risks, diabetes, and sleep apnea.
Via
Benzinga
The Penny Stock Prophecy: 3 Overlooked Stocks Primed to Pop
May 27, 2024
Overlooked penny stocks are the path to outsized gains and these shares seem to fit the bill at the moment.
Via
InvestorPlace
10 Best Vanguard Funds to Buy Right Now
May 27, 2024
These 10 Vanguard stock ETFs can help you build a top-notch portfolio.
Via
The Motley Fool
Topics
ETFs
Chinese Scientists Achieve World's First Diabetes Cure Using Cell Therapy: Report
May 27, 2024
A team of Chinese scientists has successfully cured a patient's diabetes using cell therapy, marking a global first.
Via
Benzinga
Got $500? 3 Pharma Stocks to Buy and Hold Forever
May 26, 2024
These players might even beat the market when the conditions are right.
Via
The Motley Fool
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
May 26, 2024
The gold rush for obesity medications just got a bit more intense.
Via
The Motley Fool
3 High-Flying Stocks That Could Soar Even More
May 25, 2024
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.
Via
The Motley Fool
Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford
May 25, 2024
Elon Musk predicts that Novo Nordisk's weight-loss drug Ozempic will eventually become very cheap, following its depiction in a new South Park special as a luxury medication accessible only to the...
Via
Benzinga
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds
May 24, 2024
Eli Lilly has significantly increased its investment in its Lebanon, Indiana, manufacturing site to $9 billion, aiming to enhance production of tirzepatide injections.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 24, 2024
Via
Benzinga
Stock Market Hits A Wall Despite Booming Nvidia: Weekly Review
May 24, 2024
The Nasdaq and S&P 500 hit record highs, but fell back.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Jim Cramer Says This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks
May 24, 2024
"All of these stocks are a little volatile right now, but I think you want to own it and buy it into the volatility," Jim Cramer says.
Via
Benzinga
Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now
May 24, 2024
Most Dow stocks are strong investments but these 7 stand out at the moment as the macroenvironment trends positive again.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
7 Stocks to Buy if the Market Ends Up Plunging
May 24, 2024
If the bears finally catch up to the bulls and take them down, these are the proven stocks to buy if the market falls.
Via
InvestorPlace
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
May 23, 2024
Weight loss drugs get the new parody treatment in a "South Park" streaming special.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bonds Break Down And Send Everyone To Cash
May 23, 2024
This situation is where the danger, the opportunity, and the action are right now.
Via
Talk Markets
3 Biotech Stocks to Buy on the Dip: May 2024
May 23, 2024
These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.
Via
InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
May 23, 2024
Via
Benzinga
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study
May 23, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study
May 23, 2024
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
3 Blue Chip Stocks That You Can Buy and Hold for Years
May 23, 2024
You won't be taking on much risk by investing in these stalwarts.
Via
The Motley Fool
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
May 23, 2024
The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders.
Via
InvestorPlace
Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
May 22, 2024
Compounding weight loss drugs, which are similar to brand-name medications such as Ozempic and Mounjaro, will be banned in Australia.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.